Question special
Lead Moderator

FH patients were not explicitly included in the FOURIER trial. Presumably there were FH patients with CVD and elevated LDL-C levels despite moderate/high intensity statin therapy. Many payers said they were waiting for CV outcomes trial results. Do you see FOURIER results improving access for FH patients with CVD? How about access for primary prevention FH patients?